A phase II trial of saracatinib, an inhibitor of src kinases, in previously-treated advanced non-small-cell lung cancer: the princess margaret hospital phase II consortium.
暂无分享,去创建一个
A. Oza | M. Tsao | F. Shepherd | G. Nicholas | J. Wright | J. Schwock | N. Leighl | V. Hirsh | G. Goss | M. Reaume | S. Laurie | Lisa Wang | Lindsay Philip